Pharmaceutical PV DIV - FSB
Ended Awarded
- Contract number
- SPE2DU26FDZ74
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,134
Award facts
- Contract value 100% obligated
- $2,133.51 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $2,133.51 to AmerisourceBergen Drug Corp on November 17, 2025, under the Pharmaceutical Photovolataic Division contract (4570030465). This firm fixed-price delivery order, with an ultimate completion date of November 18, 2025, represents a child contract utilizing AmerisourceBergen's existing indefinite delivery vehicle with DLA. The award was made on a competitive basis without set-aside restrictions. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor and healthcare solutions provider for federal medical procurement, with particular focus on military and veteran healthcare systems.
This delivery order falls under AmerisourceBergen's broader DLA Troop Support Medical prime IDC (SPE2DX), a $999.99 billion indefinite delivery contract running through December 2026 that enables global pharmaceutical support for military healthcare programs. The parent IDC encompasses a comprehensive range of pharmaceutical products and medical supplies, including brand-name and generic medications, vaccines, specialty treatments for conditions such as diabetes and neurological disorders, and medical devices. AmerisourceBergen's performance under the DLA contract vehicle demonstrates the company's capability to meet federal procurement requirements for diverse medical supply needs across multiple therapeutic domains, supporting customers including the Defense Health Agency and U.S. Coast Guard.
Quick answers
Who was awarded contract SPE2DU26FDZ74?
SPE2DU26FDZ74 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 17, 2025.
How much is contract SPE2DU26FDZ74 worth?
The government has obligated $2,134 on SPE2DU26FDZ74.
Is contract SPE2DU26FDZ74 an order under another contract?
Yes. SPE2DU26FDZ74 is a delivery order under SPE2DU25D3107, an indefinite delivery contract.
Was contract SPE2DU26FDZ74 competed?
The extent of competition for SPE2DU26FDZ74 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award